Biogen to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Biogen to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Cambridge, MA, - - Biogen Inc. (Nasdaq: BIIB) announced today that Michael McDonnell, Chief Financial Officer, and Priya Singhal, M.D., M.P.H., Head of Development, will participate in a fireside chat during the Morgan Stanley 22nd Annual Global Healthcare Conference. The webcast will be live on Wednesday, September 4, 2024, at 10:00 a.m. ET. To access the live webcast, please visit the Investors section of Biogen's website at investors.biogen.com. An archived version of the webcast will be available for at least 30 days following the presentation.
馬薩諸塞州劍橋市-渤健公司(Nasdaq: BIIB)今天宣佈，首席財務官邁克爾·麥克唐納和開發負責人Priya Singhal將在摩根士丹利第22屆全球醫療保健大會上舉行爐邊聊天。網絡廣播將於2024年9月4日上午10:00在ET上直播。要訪問現場網絡廣播，請訪問Biogen網站的投資者部分，網址爲investors.biogen.com。演示後將提供至少30天的歸檔版本。
About Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient's lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
關於渤健公司
渤健公司成立於1978年，是一家領先的生物技術公司，開展創新科學，推出新藥品，改變患者的生命，併爲股東和我們的社區創造價值。我們深刻了解人類生物學，並利用不同的模式來推進首創治療或療法，提供優越的治療結果。我們的方法是冒着大膽的風險，平衡回報，實現長期增長。
We routinely post information that may be important to investors on our website at . Follow us on social media - Facebook, LinkedIn, X, YouTube.
我們定期在網站上發佈可能對投資者重要的信息。請關注我們在社交媒體上的動態- Facebook，LinkedIn，X，YouTube。